IHEvsIJH
iShares U.S. Pharmaceuticals ETF against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | IJH | |
|---|---|---|
| Expense ratio | 0.37% | 0.050% |
| Assets | $1.7B | $123.7B |
| Net flow, 1 month | +$49M | +$109M |
| Net flow, 1 year | +$722M | +$10.7B |
| Return, YTD | +29.2% | +10.2% |
| Return, 1 year | — | — |
| Avg daily volume | 270K | 8.1M |
| Holdings | 52 | 408 |
| Listed | May 1, 2006 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS